INDOLENT LYMPHOMA
Clinical trials for INDOLENT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INDOLENT LYMPHOMA trials appear
Sign up with your email to follow new studies for INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to tame Slow-Growing blood cancers
Disease control Not yet recruitingThis Phase II trial will test a combination of pomalidomide, an anti-CD20 antibody, and prednisone as a first treatment for people with indolent (slow-growing) B-cell lymphomas. About 30 adults who have not had prior therapy will receive six cycles of the combo, followed by two y…
Matched conditions: INDOLENT LYMPHOMA
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New pill shows promise for Hard-to-Treat lymphoma patients
Disease control Not yet recruitingThis Phase 2 trial tests lisaftoclax, an oral drug that blocks a protein helping cancer cells survive. It enrolls 75 adults with certain slow-growing lymphomas (CLL, WM, or MZL) who either cannot take standard BTK inhibitors due to health issues or have stopped them due to side e…
Matched conditions: INDOLENT LYMPHOMA
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy targets Hard-to-Treat lymphoma
Disease control Not yet recruitingThis study tests a combination of two drugs, pomalidomide and obinutuzumab, in people with slow-growing lymphomas (like follicular lymphoma) that have returned or not responded to prior therapy. The first part finds the safest dose, and the second part checks how well the combina…
Matched conditions: INDOLENT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC